Nature Reviews Urology

Papers
(The TQCC of Nature Reviews Urology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything215
Texture analysis for patient selection202
Single-cell and spatial sequencing of kidney cancer149
Human-relevant urothelial model provides insight into infection strategies and host response135
Krause corpuscles act as genital vibration detectors108
Semen quality recovery following COVID-19100
PARP inhibitors plus enzalutamide to treat mCRPC83
High-dose chemotherapy for relapsed testicular germ cell tumours79
Urine microbiota differ in bladder cancer77
Considering urology in a planetary context76
Time for women-centred gynaecology73
Preclinical models of bladder cancer: BBN and beyond73
Advancing the state of the art in congenital obstructive uropathy69
A clinical guide to rare male sexual disorders69
Micro-ultrasound for prostate cancer65
Symptoms and subtypes of patients with lower urinary tract dysfunction — insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network64
Proteomic-based analysis of testicular interstitial fluid61
FOXA2–KIT-driven lineage plasticity in NEPC58
Overcoming antibiotic resistance in complicated UTI55
A new text message-based platform for self-management of patients with IC/BPS55
What happens in Vegas … shapes the future of urology53
Madrid plays host to a celebration of urology53
Microfluidic sperm selection53
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations52
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer52
Leveraging generative AI to enhance doctor–patient communication51
Promise without practice — charting the path forward for bladder cancer biomarkers51
Metaverse in surgery — origins and future potential47
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers47
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence47
Pembrolizumab + axitinib beyond first-line therapy for mRCC46
A non-invasive assay for UTUC diagnosis44
Vaccination to prevent untreatable gonorrhoea44
COVID can’t kill CopMich collaboration44
Personalized 3D models for prostate cancer surgery42
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology42
Efficacy of the Revi system in treating urgency urinary incontinence41
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications41
Resolving the puzzle of same-sex sexual interactions39
PEACEing together prostate cancer therapy39
EMUC25: shaping tomorrow’s uro-oncology care39
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility38
Measuring and improving the cradle-to-grave environmental performance of urological procedures36
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment35
Transitional urology: a comprehensive review of the transitional care process34
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway34
Effect of high glucose on E. coli33
The mechanism of action of neuromodulation in the treatment of overactive bladder33
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC32
The magic of MagSToNE31
Secondary kidney stones — remove or leave?30
Cribriform morphology affects mpMRI imaging29
A distinct TAM subset mediates immunotherapy resistance in prostate cancer29
Women in urology: the past29
AUA returns to its former glory in Chicago27
Promising efficacy of UTI vaccines as an alternative to antibiotics27
Robots learning to imitate surgeons — challenges and possibilities26
Prostate cancer in transgender women — challenges in research and clinical care26
Technical modifications to improve erectile function recovery after radical prostatectomy26
Microultrasonography-guided prostate cancer biopsy25
Videourodynamics — role, benefits and optimal practice25
A clinical overview of people living with HIV and genitourinary cancer care24
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease24
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?24
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective23
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards23
Is it time to rethink the current patient-reported outcome measures?23
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer23
Successful mentorship for women in urology — a new era23
Current and emerging strategies to curb antibiotic-resistant urinary tract infections23
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer22
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD22
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer22
Pride, not prejudice21
AI for antibiotic design20
Turning up the heat: CTLA4 blockade in urothelial cancer20
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning20
Androgen receptor pathway inhibitor combination in prostate cancer19
Beyond maternal exercise: paternal exercise adaptations mediated by sperm microRNA signatures19
Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health19
Management and cost of stent encrustation in pregnancy18
Immune-based therapies in penile cancer17
The future of patient-derived xenografts in prostate cancer research17
De-clear cell differentiated renal cell carcinoma — a new therapeutic target16
The prognostic role of stroma in UTUC16
The evolving treatment landscape of metastatic urothelial cancer16
Turning back time in the testes15
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself15
Uncovering a link between COVID-19 and renal cell carcinoma15
The value of women urologists — individual and institutional imperatives to address salary equity15
We all get erections — de-gendering sexual arousal dysfunction in the ICD15
The shifting treatment paradigm of metastatic renal cell carcinoma15
Improved phenotypic classification of male infertility to promote discovery of genetic causes14
Urinary tract infections in children14
Pelvic-fascia-sparing techniques and outcomes with RARP14
Och AI the noo from SIU14
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome13
The unclear role of PET–CT in localized radiorecurrent prostate cancer13
Hallmark discoveries in the biology of Wilms tumour12
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy12
Current and future pharmacotherapy for female sexual dysfunction12
Men hold the balance of power12
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer12
Power up to investigate PrEP11
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer11
CMA mediates resistance to androgen inhibitors in prostate cancer11
BAUSing back in Birmingham11
Effects of COVID-19 vaccine on semen parameters11
Tuft cells in prostate cancer11
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI10
Male infertility and somatic health — insights into lipid damage as a mechanistic link10
Metabolism, mitochondria and metastasis in kidney cancer10
Mechanisms of the intestinal and urinary microbiome in kidney stone disease10
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications10
Diagnosis of ccRCC10
Semen parameters across testicular cancer stages10
Spatiotemporal trends in human semen quality10
Mellow yellow: BilR reduces bilirubin to urobilinogen10
The ins and outs of penile erection9
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS9
MRI diagnosis and radical prostatectomy outcomes9
Chlorination by-products in drinking water — association with bladder cancer risk9
Syphilis on the rise — a need for alternative therapies and vaccines9
Stepping up to prevent bacterial vaginosis recurrence9
Pronouns in English: a user’s guide9
Sperm activity affected by endometriosis9
Testosterone replacement therapy and spermatogenesis in reproductive age men9
Advances in sliding clip renorrhaphy for partial nephrectomy9
Influence of substance use on male reproductive health and offspring outcomes8
Artificial intelligence in the management of prostate cancer8
Smooth muscle cell plasticity in pelvic organ prolapse8
A great gathering at the 4th Clinical and Scientific Advances in UTI conference8
Clinical trial design for non-muscle-invasive bladder cancer8
Visual clues — dermatological manifestations of sexually transmitted infections in men8
Particulate matter leaves a bitter taste in testes8
Feasibility and potential of an MRI-based prostate cancer screening7
Urology on a changing planet: links between climate change and urological disease7
Prescribing clinician specialty influences adherence to PrEP7
ADT intensification to treat biochemically recurrent prostate cancer7
Genetic and biological drivers of prostate cancer disparities in Black men7
The future of pelvic lymph node dissection for urological malignancies7
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning7
Revisiting the dual role of androgens and oestrogens in mammalian sex differentiation with a focus on genitalia7
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma7
The effects of diet on prostate cancer outcomes7
EAU26: innovation, patient care and a touch of mythology7
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects7
0.11679410934448